Research programme: growth factor modulators - Scholar Rock

Drug Profile

Research programme: growth factor modulators - Scholar Rock

Alternative Names: Niche modulators - Scholar Rock

Latest Information Update: 08 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Scholar Rock
  • Class Antifibrotics; Antineoplastics
  • Mechanism of Action Bone morphogenetic protein receptor antagonists; Myostatin inhibitors; TGF-beta superfamily protein inhibitors; TGF-beta superfamily protein-modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Spinal muscular atrophy
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Anaemia; Autoimmune disorders; Fibrosis; Musculoskeletal disorders; Spinal cord injuries; Spinal muscular atrophy

Most Recent Events

  • 03 Jan 2018 Preclinical trials in Anaemia in USA before January 2018
  • 15 Sep 2014 Preclinical trials in Autoimmune disorders in USA (unspecified route)
  • 15 Sep 2014 Preclinical trials in Fibrosis in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top